Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world...

Area of Science:

• Hepatology
• Clinical Diagnostics
• Risk Stratification

Background:

• Nonalcoholic fatty liver disease (NAFLD) requires validated, accessible methods for routine risk assessment.
• Identifying patients at risk of adverse outcomes is crucial for timely intervention.

Purpose of the Study:

• To validate the prognostic utility of Fibrosis-4 (FIB-4) and liver stiffness measurement (LSM) for risk-stratifying NAFLD patients.
• To assess the association of FIB-4/LSM categories with adverse clinical outcomes.

Main Methods:

• Retrospective-prospective analysis of 2523 NAFLD patients from the TARGET-NASH study.
• Patients categorized into three risk groups (A, B, C) based on FIB-4 scores and LSM values.
• Fine-Gray competing risk analyses were used to evaluate outcomes.

Main Results:

• Adverse outcomes, including mortality and liver-specific events, significantly increased from risk class A to C.
• Hazard ratios demonstrated a clear gradient of risk across the FIB-4/LSM categories.
• Upstaged patients exhibited outcome rates comparable to the lower risk class defined by FIB-4.

Conclusions:

• The FIB-4 score provides a reliable tool for risk-stratifying NAFLD patients in routine clinical practice.
• This stratification aids in identifying individuals who may benefit from closer monitoring and management.
• The study supports the integration of FIB-4 into standard NAFLD patient assessment.